DC Funds, LP
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), DC Funds, LP reported 3 stock positions worth $10.3 million. Its top holding was Tscan Therapeutics (TCRX) at 48.3% of the portfolio, followed by Werewolf Therapeutics (HOWL, 36.9%) and Barinthus Biotherapeutics PL (BRNS, 14.8%). Its holdings were unchanged from Q4 2023.
- Most Recent 13F
- Q2 2026
- Location
- MCLEAN, VA
- CIK
- 0001869028
- Portfolio Value
- $10.3M (Q1 2024)
- SEC Filing
- 0001398344-24-009524 ↗ filed May 14, 2024
Holdings Value
Holdings 3 stocks · $10.3M
Portfolio Sells Q4 2023 → Q1 2024
| None this quarter. | |||
Portfolio Buys Q4 2023 → Q1 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 3 | $1.3M | TCRX, BRNS, HOWL |
| Q1 2026 | 3 | $1.5M | TCRX, HOWL, BRNS |
| Q4 2025 | 3 | $1.5M | TCRX, BRNS, HOWL |
| Q3 2025 | 3 | $3.1M | HOWL, TCRX, BRNS |
| Q2 2025 | 3 | $2.2M | TCRX, HOWL, BRNS |
| Q1 2025 | 3 | $2.1M | TCRX, BRNS, HOWL |
| Q4 2024 | 3 | $3.6M | TCRX, HOWL, BRNS |
| Q3 2024 | 3 | $5.2M | TCRX, HOWL, BRNS |
| Q2 2024 | 3 | $6.0M | TCRX, HOWL, BRNS |
| Q1 2024 | 3 | $10.3M | TCRX, HOWL, BRNS |